Christopher McCabe
Impact in
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
- Economic and Environmental Valuation
- General Health Professions top 2%
- Healthcare cost, quality, practices
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 71
- Pharmaceutical Economics and Policy 22
- Healthcare Policy and Management 17
- Economic and Environmental Valuation 11
-
- Healthcare cost, quality, practices 20
- Global Health Care Issues 11
- Co-authors
- Karl Claxton (11 shared papers)Anthony J. Culyer (8 shared papers)Aki Tsuchiya (5 shared papers)Richard Edlin (25 shared papers)Devidas Menon (7 shared papers)Tania Stafinski (7 shared papers)Peter S Hall (29 shared papers)John Brazier (8 shared papers)
- Journals
- PharmacoEconomics (21 papers)Value in Health (10 papers)Health Technology Assessment (5 papers)Trials (5 papers)Medical Decision Making (4 papers)
- Partner nations
- United KingdomCanadaNew Zealand
In The Last Decade
Christopher McCabe
125 papers receiving 4.0k citations
Christopher McCabe's Hit Papers
Peers
Comparison fields: 5 of 162
- Economics and Econometrics 1.6k
- General Health Professions 518
- Cancer Research 261
- Oncology 387
- Physiology 278
Countries citing papers authored by Christopher McCabe
This map shows the geographic impact of Christopher McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McCabe more than expected).
Fields of papers citing papers by Christopher McCabe
This network shows the impact of papers produced by Christopher McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McCabe. The network helps show where Christopher McCabe may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher McCabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The NICE Cost-Effectiveness Threshold Hit paper breakdown → | 2008 | 632 |
| 2 | 2011 | 199 | |
| 3 | 2008 | 176 | |
| 4 | 2005 | 159 | |
| 5 | 2017 | 155 | |
| 6 | 2016 | 153 | |
| 7 | 2007 | 136 | |
| 8 | 2008 | 115 | |
| 9 | 2011 | 109 | |
| 10 | 2010 | 109 | |
| 11 | 2006 | 107 | |
| 12 | 2015 | 80 | |
| 13 | 2014 | 78 | |
| 14 | 2010 | 67 | |
| 15 | 2011 | 66 | |
| 16 | 2004 | 62 | |
| 17 | 2016 | 59 | |
| 18 | 2011 | 59 | |
| 19 | 2008 | 53 | |
| 20 | 2009 | 49 |
About Christopher McCabe
Christopher McCabe is a scholar working on Economics and Econometrics, General Health Professions, Cancer Research, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 125 papers that have together received 4.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (71 papers), Pharmaceutical Economics and Policy (22 papers), Healthcare cost, quality, practices (20 papers), Healthcare Policy and Management (17 papers), Economic and Environmental Valuation (11 papers), Global Health Care Issues (11 papers), Breast Cancer Treatment Studies (7 papers) and Biomedical Ethics and Regulation (6 papers). The work is most often cited by research in Economics and Econometrics (1.6k citations), General Health Professions (518 citations), Cancer Research (261 citations), Oncology (387 citations) and Physiology (278 citations). Christopher McCabe has collaborated with scholars based in United Kingdom, Canada and New Zealand. Frequent co-authors include Karl Claxton, Anthony J. Culyer, Aki Tsuchiya, Richard Edlin, Devidas Menon, Tania Stafinski, Peter S Hall, John Brazier, Katherine Stevens and Mike Paulden. Their work appears in journals such as PharmacoEconomics, Value in Health, Health Technology Assessment, Trials and Medical Decision Making.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.